House Subcommittee Recommends $137.7 Million Increase For NCI
In Brief: GM awards Shared By Six Scientists; Pollard Named President of Salk Institute
NCI Names Brawly Director of Office of Special Populations
Owens Becomes President, NCCR
FDA approves Irinotecan, Days After ODAC Meeting
ODAC Recommends FDA Approval For Grain Tumor Implant
Letter: Headline Criticized On Letter About Consortium
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Tumors are able to form with no DNA mutations, fly study shows
- From clinician scientist to nonprofit CEO